JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanonaka, K.
Right arrow Articles by Takeo, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanonaka, K.
Right arrow Articles by Takeo, S.

Vol. 291, Issue 2, 710-716, November 1999

Role of an ATP-Sensitive Potassium Channel Opener, YM934, in Mitochondrial Energy Production in Ischemic/Reperfused Heart

Kouichi Tanonaka, Taku Taguchi, Miki Koshimizu, Tsuyoshi Ando, Tomohiro Morinaka, Tomoya Yogo, Fusako Konishi and Satoshi Takeo

Department of Pharmacology, Tokyo University of Pharmacy and Life Science, Hachioji, Japan

We examined a possible mechanism of action of an ATP-sensitive potassium (KATP) channel opener, YM934, for the improvement of energy metabolism in hearts subjected to 35-min ischemia and 60-min reperfusion. The treatment with 30 nM YM934 for the final 15 min of preischemia enhanced postischemic recovery of left ventricular developed pressure, attenuated the postischemic rise in left ventricular end-diastolic pressure, and suppressed the release of creatine kinase and ATP metabolites during reperfusion. The treatment also restored myocardial ATP and creatine phosphate contents and attenuated the decrease in mitochondrial oxygen consumption rate during reperfusion. The higher mitochondrial function was also seen in YM934-treated hearts at the end of ischemia. In another set of experiments, myocardial skinned bundles were incubated for 30 min under hypoxic conditions in the presence and absence of YM934, and then mitochondrial oxygen consumption rate was determined. Hypoxia decreased the mitochondrial oxygen consumption rate of skinned bundles to approximately 40% of the prehypoxic value. In contrast, the treatment of skinned bundles with 30 nM YM934 preserved the mitochondrial oxygen consumption rate during hypoxia. The effect of YM934 on the hypoxic skinned bundles was abolished by combined treatment with either the KATP channel blocker glyburide or the mitochondrial KATP channel blocker 5-hydroxydecanoate in a concentration-dependent manner. The results suggest that YM934 is capable of attenuating ischemia/reperfusion injury of isolated perfused hearts due to preservation of mitochondrial function during ischemia, probably through opening of mitochondrial KATP channels.


0022-3565/99/2912-0710$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
K. Naitoh, Y. Ichikawa, T. Miura, Y. Nakamura, T. Miki, Y. Ikeda, H. Kobayashi, M. Nishihara, K. Ohori, and K. Shimamoto
MitoKATP channel activation suppresses gap junction permeability in the ischemic myocardium by an ERK-dependent mechanism
Cardiovasc Res, May 1, 2006; 70(2): 374 - 383.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. O'Rourke
Evidence for Mitochondrial K+ Channels and Their Role in Cardioprotection
Circ. Res., March 5, 2004; 94(4): 420 - 432.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. J Hausenloy, H. L Maddock, G. F Baxter, and D. M Yellon
Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
Cardiovasc Res, August 15, 2002; 55(3): 534 - 543.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T.-M. Lee, S.-F. Su, T.-F. Chou, and C.-H. Tsai
Pharmacologic preconditioning of estrogen by activation of the myocardial adenosine triphosphate-sensitive potassium channel in patients undergoing coronary angioplasty
J. Am. Coll. Cardiol., March 6, 2002; 39(5): 871 - 877.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Tanonaka, K.-I. Furuhama, H. Yoshida, K. Kakuta, Y. Miyamoto, W. Toga, and S. Takeo
Protective effect of heat shock protein 72 on contractile function of perfused failing heart
Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H215 - H222.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. Ozcan, E. L. Holmuhamedov, A. Jahangir, and A. Terzic
Diazoxide protects mitochondria from anoxic injury: Implications for myopreservation
J. Thorac. Cardiovasc. Surg., February 1, 2001; 121(2): 0298 - 306.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.